Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
3(18%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_2
3
18%
Ph not_applicable
3
18%
Ph phase_3
6
35%
Ph phase_1
1
6%

Phase Distribution

1

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
6(46.2%)
N/ANon-phased studies
3(23.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(5)
Completed(6)
Other(6)

Detailed Status

Completed6
unknown6
Not yet recruiting2
Active, not recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (7.7%)
Phase 23 (23.1%)
Phase 36 (46.2%)
N/A3 (23.1%)

Trials by Status

not_yet_recruiting212%
recruiting16%
active_not_recruiting212%
completed635%
unknown635%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07008833Not Applicable

Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer

Not Yet Recruiting
NCT03875781Phase 3

Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer

Recruiting
NCT02685605Phase 3

Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

Active Not Recruiting
NCT06944470Phase 2

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

Not Yet Recruiting
NCT03879109Phase 3

Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer

Active Not Recruiting
NCT01581840Phase 1

Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus

Completed
NCT05217212

Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?

Unknown
NCT03418909

Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma

Unknown
NCT02516501Not Applicable

Impact of a Ketogenic Diet Intervention During Radiotherapy on Body Composition

Completed
NCT02469922Not Applicable

Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer

Completed
NCT01362127Phase 2

Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia

Completed
NCT02745691

Psychometric Properties of the EORTC QLQ-LC29

Completed
NCT03963882Phase 2

NAC Followed by RH for the Treatment of LACC

Unknown
NCT01873469

Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme

Completed
NCT03366883Phase 3

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

Unknown
NCT00738790Phase 3

Preoperative Radiotherapy and Local Excision in Rectal Cancer

Unknown
NCT00833131Phase 3

The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17